Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on profitability.
Zacks
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on profitability.
Zacks
More News
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Western Digital's Q1 Earnings & Revenues Beat, Dividend Hiked by 17%
WDC's fiscal Q1 earnings and revenue beat estimates, fueled by strong cloud demand and pricing gains, as higher-capacity drives and new technology transitions drive growth.
Zacks
Quest Diagnostics confirms patient information accessed in cyberattack, systems temporarily shut down
Quest Diagnostics confirmed that patient health information or personally identifiable information was involved in a cybersecurity breach that prompted the medical testing giant to temporarily suspend access to several systems.The New Jersey-based company said Thursday that it disabled access to...
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Quest Diagnostics beats Q3 earnings and revenue estimates, raises its 2026 outlook on strong testing demand and margin gains, yet shares dip in pre-market trading.
Quest Diagnostics (NYSE:DGX) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzingaread more...
Benzinga
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
Quest Diagnostics (DGX) delivered earnings and revenue surprises of +5.26% and +1.72%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Quest Diagnostics Announces Increase In Q3 Income
(RTTNews) - Quest Diagnostics (DGX) reported a profit for its third quarter that Increases, from last year...